CY963A - Dopamine derivatives - Google Patents

Dopamine derivatives

Info

Publication number
CY963A
CY963A CY963A CY96373A CY963A CY 963 A CY963 A CY 963A CY 963 A CY963 A CY 963A CY 96373 A CY96373 A CY 96373A CY 963 A CY963 A CY 963A
Authority
CY
Cyprus
Prior art keywords
dopamine derivatives
dopamine
derivatives
Prior art date
Application number
CY963A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY963(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY963A publication Critical patent/CY963A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY963A 1972-04-12 1973-04-09 Dopamine derivatives CY963A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
CY963A true CY963A (en) 1978-12-22

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
CY963A CY963A (en) 1972-04-12 1973-04-09 Dopamine derivatives

Country Status (31)

Country Link
JP (2) JPS5825656B2 (lv)
KR (1) KR790000113B1 (lv)
AR (1) AR203822A1 (lv)
AT (1) AT323719B (lv)
AU (1) AU472734B2 (lv)
BE (1) BE798051A (lv)
BG (1) BG23001A3 (lv)
CA (1) CA1018188A (lv)
CH (2) CH569691A5 (lv)
CS (2) CS190448B2 (lv)
CY (1) CY963A (lv)
DD (1) DD107670B3 (lv)
DE (1) DE2317710C2 (lv)
DK (1) DK142750C (lv)
ES (1) ES413639A1 (lv)
FR (1) FR2182947B1 (lv)
GB (1) GB1392674A (lv)
HK (1) HK50178A (lv)
HU (2) HU167597B (lv)
IE (1) IE37511B1 (lv)
IL (1) IL42016A (lv)
KE (1) KE2870A (lv)
MY (1) MY7800381A (lv)
NL (1) NL174459C (lv)
PH (1) PH11041A (lv)
PL (2) PL90695B1 (lv)
RO (2) RO65105A (lv)
SE (1) SE399064B (lv)
SU (1) SU496719A3 (lv)
YU (2) YU36483B (lv)
ZA (1) ZA732136B (lv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (lv) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (lv) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
PT1546088E (pt) 2002-10-03 2015-03-16 Novaremed Ltd Compostos para utilização no tratamento de doenças auto-imunes, de doenças imuno-alérgicas e de rejeição de órgãos ou tecidos transplantados
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
JP2013501006A (ja) 2009-07-31 2013-01-10 コグニション セラピューティクス インク． 認知機能低下の阻害剤
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
BR112014004414A2 (pt) * 2011-08-25 2017-03-28 Cognition Therapeutics Inc composições e métodos para tratar doença neurodegenerativa
BR112016017808B1 (pt) 2014-01-31 2022-07-12 Cognition Therapeutics, Inc Composto ou sal farmaceuticamente aceitável, uso de um composto e composição para a inibição de um efeito betaamilóide numa célula neuronal
KR102614814B1 (ko) 2017-05-15 2023-12-20 카그니션 테라퓨틱스, 인코퍼레이티드 신경변성 질환 치료용 조성물
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
YU36483B (en) 1984-02-29
AR203822A1 (es) 1975-10-31
CA1018188A (en) 1977-09-27
IL42016A (en) 1976-05-31
YU97673A (en) 1982-02-25
IE37511B1 (en) 1977-08-03
BG23001A3 (bg) 1977-05-20
DE2317710C2 (de) 1983-08-04
PL94207B1 (lv) 1977-07-30
ZA732136B (en) 1974-03-27
CH580563A5 (lv) 1976-10-15
HU166213B (lv) 1975-02-28
AU5438573A (en) 1974-10-17
DK142750C (da) 1981-08-17
DD107670B3 (de) 1988-04-06
YU37113B (en) 1984-08-31
NL7305097A (lv) 1973-10-16
DD107670A5 (de) 1974-08-12
JPS5825656B2 (ja) 1983-05-28
FR2182947A1 (lv) 1973-12-14
RO65105A (ro) 1980-01-15
CH569691A5 (lv) 1975-11-28
KR790000113B1 (en) 1979-03-20
JPS58131945A (ja) 1983-08-06
SU496719A3 (ru) 1975-12-25
BE798051A (fr) 1973-10-11
AU472734B2 (en) 1976-06-03
SE399064B (sv) 1978-01-30
PH11041A (en) 1977-10-25
DE2317710A1 (de) 1973-10-18
HU167597B (lv) 1975-11-28
GB1392674A (en) 1975-04-30
HK50178A (en) 1978-09-15
DK142750B (da) 1981-01-12
IL42016A0 (en) 1973-06-29
JPS497237A (lv) 1974-01-22
NL174459C (nl) 1984-06-18
CS190406B2 (en) 1979-05-31
KE2870A (en) 1978-09-01
YU321279A (en) 1983-04-27
FR2182947B1 (lv) 1976-07-02
AT323719B (de) 1975-07-25
NL174459B (nl) 1984-01-16
PL90695B1 (lv) 1977-01-31
JPS6221343B2 (lv) 1987-05-12
RO70892A (ro) 1982-02-26
CS190448B2 (en) 1979-05-31
MY7800381A (en) 1978-12-31
ES413639A1 (es) 1976-01-16

Similar Documents

Publication Publication Date Title
IL43795A (en) 3-aminoalkylamino-1-phenoxy-2-propanol derivatives
ZA741280B (en) Thiazole derivatives
ZA732136B (en) Dopamine derivatives
ZA733812B (en) Cysteine derivatives
IL41060A0 (en) Alpha-aryl-4-substituted piperidinoalkanol derivatives
ZA736059B (en) New quinoxaline-di-n-oxide derivatives
CY992A (en) Benzocycloheptathiophene derivatives
GB1402219A (en) Berbine derivatives
ZA728917B (en) Oxaziniondole-and thiaziniondole derivatives
IL42943A (en) 16-methyl-prednisolone derivatives
IL41789A0 (en) Diphenylalkyllactamimide derivatives
IL43280A0 (en) Amidinourea derivatives
PH10465A (en) Debenzazecine derivatives
GB1405227A (en) Pheynlthioethyl-imidazole derivatives
KE2917A (en) New phenylformamidine derivatives
ZA728875B (en) Pyrano-and thiopyranoindole derivatives
ZA734945B (en) New beta-aminoketone derivatives
IE38616L (en) Diphenylamine derivatives
AU5872373A (en) Isoxolidine derivatives
PH10601A (en) Diaza-oxa-bicyclodecane derivatives
AU5423773A (en) Alpha-pyrone derivatives
HK380A (en) Benzoisoindoline derivatives
PH10653A (en) Indolylimidoylquinoline derivatives
AU5916873A (en) Cyclohexanepentol derivative
GB1404382A (en) Homopyrimidazole derivatives